{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:54:32Z","timestamp":1759042472915},"reference-count":25,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,6]]},"DOI":"10.18632\/oncotarget.16936","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T02:09:34Z","timestamp":1491617374000},"page":"36964-36972","source":"Crossref","is-referenced-by-count":10,"title":["Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis"],"prefix":"10.18632","volume":"8","author":[{"given":"Yusuke","family":"Takei","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyuki","family":"Ueshima","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki R.","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariyo","family":"Rokutan-Kurata","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Moriyoshi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"},{"name":"Department of Diagnostic Pathology, Kyoto Medical Center, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Pathology, Japan Red Cross Society Wakayama Medical Center, Wakayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Kochi University Faculty of Medicine, Nankoku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanju","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology & Therapeutics, Division of Physiology & Pathology, Showa University School of Pharmacy, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"1","first-page":"258","article-title":"KIR2DL4 (CD158d): An activation receptor for HLA-G","volume":"3","author":"Long","year":"2012","journal-title":"Front Immunol"},{"key":"2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-61779-842-9_23","article-title":"Overview of the killer cell immunoglobulin-like receptor system","volume":"882","author":"Rajalingam","year":"2012","journal-title":"Methods Mol Biol"},{"key":"3","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.4049\/jimmunol.168.12.6208","article-title":"KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential","volume":"168","author":"Long","year":"2002","journal-title":"J Immunol"},{"key":"4","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.4049\/jimmunol.180.5.2922","article-title":"KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules","volume":"180","author":"Campbell","year":"2008","journal-title":"J Immunol"},{"key":"5","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.4049\/jimmunol.174.7.3859","article-title":"Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor protein","volume":"174","author":"Campbell","year":"2005","journal-title":"J Immunol"},{"key":"6","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.4049\/jimmunol.171.7.3415","article-title":"KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN- production","volume":"171","author":"Campbell","year":"2003","journal-title":"J Immunol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4049\/jimmunol.167.4.1877","article-title":"Cutting edge: induction of IFN- production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells","volume":"167","author":"Long","year":"2001","journal-title":"J Immunol"},{"key":"8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/molehr\/gap039","article-title":"The genotype of the NK cell receptor, KIR2DL4, influences INF secretion by decidual natural killer cells","volume":"15","author":"Witt","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0897.2007.00469.x","article-title":"Possible roles of KIR2DL4 expression on uNK cells in human pregnancy","volume":"57","author":"Li","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/2326-6066.CIR-14-0199","article-title":"The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion","volume":"3","author":"Haga","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ajpath.2016.02.011","article-title":"Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer\/T-Cell Lymphoma","volume":"186","author":"Chan","year":"2016","journal-title":"Am J Pathol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5858\/arpa.2015-0199-RA","article-title":"Langerhans Cell Histiocytosis: A Clinicopathologic Review and Molecular Pathogenetic Update","volume":"139","author":"Brown","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Abhyankar","year":"2014","journal-title":"J Exp Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1182\/blood-2012-06-429597","article-title":"BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis","volume":"120","author":"von Deimling","year":"2012","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Elenitoba-Johnson","year":"2014","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Hu","year":"2014","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cellimm.2005.01.008","article-title":"A human Langerhans cell-like cell line, ELD-1, promotes CD8 T cells to produce IFN- through CD70-dependent alternative pathway","volume":"232","author":"Miyazaki","year":"2004","journal-title":"Cell Immunol"},{"key":"18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3892\/or.2014.3567","article-title":"Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics","volume":"33","author":"Yoshino","year":"2015","journal-title":"Oncol Rep"},{"key":"19","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.4049\/jimmunol.0902450","article-title":"CD72 negatively regulates KIT-mediated responses in human mast cells","volume":"184","author":"Gilfillan","year":"2010","journal-title":"J Immunol"},{"key":"20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2332\/allergolint.12-OA-0450","article-title":"PD-1 Regulates the Growth of Human Mastocytosis Cells","volume":"62","author":"Haga","year":"2013","journal-title":"Allergol Int"},{"key":"21","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/srep02861","article-title":"CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1","volume":"3","author":"Haga","year":"2013","journal-title":"Sci Rep"},{"key":"22","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1073\/pnas.0710468105","article-title":"Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking","volume":"105","author":"Birchmeier","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"23","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","article-title":"Identification of a novel inhibitor of mitogen-activated protein kinase kinase","volume":"273","author":"Trzaskos","year":"1998","journal-title":"J Biol Chem"},{"key":"24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbrc.2005.08.082","article-title":"Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex","volume":"336","author":"Fujii","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes","volume":"7","author":"Parham","year":"1997","journal-title":"Immunity"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T19:37:32Z","timestamp":1589139452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":25,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,6,6]]}},"alternative-id":["16936","28445138"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16936","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}